
Results-driven Medical Science Liaison with expertise in KOL engagement, clinical trial management, and stakeholder relationships. Successfully developed over 20 KOL relationships, enhancing engagement and collaboration. Committed to delivering impactful presentations and fostering teamwork for optimal project outcomes.
Performed all types of site visits during the life cycle of assigned clinical research projects
(PSSV, SIV, IMV and COV).
● Conducted assigned site initiation visits, to include training of site personnel on Sponsor
and regulatory requirements for study conduct
● Monitored investigative clinical sites through regular interim monitoring visits according to
sponsor clinical monitoring plans with visit windows.
● Ensured strict adherence to protocol and applicable regulatory requirements via 100%
source document verification of source data with vendor electronic data capture
systems/eCRFs.
● Continuously maintained Investigator Site Files by ensuring updated essential documents
including Institutional Review Board approvals are on file.
● Monitored subject informed consent with great attention to detail for proper procedure and
instituted correction actions on identification of discrepancies.
● Confirmed eligibility of screened subjects for eligibility inclusion/exclusion criteria to ensure
appropriate randomization and screen failed subjects as applicable.
● Reviewed Adverse Events, Serious Adverse Events, and SUSARS onsite to ensure proper
reporting to Sponsor within study timelines.
● Monitor subject follow-up from 3-year clinical trial.
● Coordinate laboratory samples and compile data.
● Collaborate with medical professionals to determine changes in subjects’ conditions.
● Performed site visits to verify the suitability and viability of the investigational site for the
conduct of clinical studies in accordance with the study plan and sponsor’s SOPs
● Trained site personnel during initiation visits and managed study conduct at the site to
ensure high-level site performance.
● Performed both onsite and remote source document verification to ensure the accuracy of
data entered into the CRF/eCRF.
● Identified and tracked protocol deviations/violations along with deficiencies during
monitoring visits, and provided additional training and/or initiated corrective action as
required
● Discussed relevant visit findings with Principal Investigators via face-to-face meeting and
scheduledV
HIV Post-Exposure Prophylaxis (PEP) December 2021 Preceptor,Student and Pharmacist
Providence Saint Joseph Medical Center -June 2021
“Changing the narrative Diabetes’ Pharmacy Grand Rounds : Palmdale Regional Hospital. Palmdale
CA - 2022
“Urinary Tract Infection’’ Presented at Palmdale Regional Hospital, Audience :
Nursing/Physicians/Infectious Disease Department - Palmdale California : November 2022
“Pharmacotherapy of NSTEMI’ Presented at Palmdale Regional Hospital - November 2022
MEDICAL LIASON PRESENTATIONS THERAPEUTICS AREA